YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$15.39 USD
+0.22 (1.45%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $15.41 +0.02 (0.13%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.10 | -4.07% |
Earnings Summary
For their last quarter, YmAbs Therapeutics (YMAB) reported earnings of -$0.21 per share, missing the Zacks Consensus Estimate of -$0.13 per share. This reflects a negative earnings surprise of 61.54%. Look out for YMAB's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year increase of 44.44%.
Earnings History
Price & Consensus
Zacks News for YMAB
Celldex Therapeutics (CLDX) Reports Q2 Loss, Tops Revenue Estimates
YMAB: What are Zacks experts saying now?
Zacks Private Portfolio Services